CordovaCann (LVRLF) Free Cash Flow Growth (1y) (2015 - 2020)
CordovaCann (LVRLF) Free Cash Flow Growth (1y) (2015 - 2020) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 10.34% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -43.16% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -12.44% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 152.68% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 44.93% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -291.47% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 24.53% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 49.78% |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 89.60% |
| Mar 31, 2020 | -33.10% |
| Dec 31, 2019 | 66.69% |
| Sep 30, 2019 | 84.43% |
| Jun 30, 2019 | -11.81% |
| Mar 31, 2019 | -30.96% |
| Dec 31, 2018 | -554.42% |
| Sep 30, 2018 | -163,596.08% |
| Jun 30, 2018 | -94,922.60% |
| Mar 31, 2018 | -19,150.76% |
| Dec 31, 2017 | -8,489.50% |
| Sep 30, 2017 | 67.95% |
| Jun 30, 2017 | -100.99% |
| Mar 31, 2017 | 92.29% |
| Dec 31, 2016 | 86.30% |
| Mar 31, 2016 | 79.99% |
| Dec 31, 2015 | 79.08% |
| Mar 31, 2015 | -472.52% |